Mahler, D. A., Ohar, J. A., Barnes, C. N., Moran, E. J., Pendyala, S., & Crater, G. D. (2019). Nebulized Versus Dry Powder Long-Acting Muscarinic Antagonist Bronchodilators in Patients With COPD and Suboptimal Peak Inspiratory Flow Rate. Chronic Obstr Pulm Dis.
Citação norma ChicagoMahler, Donald A., Jill A. Ohar, Chris N. Barnes, Edmund J. Moran, Srikanth Pendyala, and Gelnn D. Crater. "Nebulized Versus Dry Powder Long-Acting Muscarinic Antagonist Bronchodilators in Patients With COPD and Suboptimal Peak Inspiratory Flow Rate." Chronic Obstr Pulm Dis 2019.
Citação norma MLAMahler, Donald A., et al. "Nebulized Versus Dry Powder Long-Acting Muscarinic Antagonist Bronchodilators in Patients With COPD and Suboptimal Peak Inspiratory Flow Rate." Chronic Obstr Pulm Dis 2019.